Also known as: Pennsaid Viscous Solution (formerly Pennsaid Gel)
Horizon Pharma (Licensor)Perrigo (Licensee)
Horizon settled a lawsuit against Perrigo resulting in Horizon granting Perrigo non-exclusive rights to commercialize a generic version of Pennsaid 2% diclofenac in the U.S.
Nuvo (Seller)Horizon Pharma (Buyer)
Horizon purchased from Nuvo U.S. rights to Pennsaid 2% diclofenac for $45 million in cash
Set Email Alert